Skip to main content
. 2016 Oct 26;7(48):78946–78957. doi: 10.18632/oncotarget.12935

Table 1. Stemness phenotype of S100A4 WT and mutants compared in the figures.

Assay WT NM CM CD
OECM1 sphere formation ++++ +++ + ++
FaDu sphere formation +++ ++ ± +
memGRP78-OECM1f +++ ++++ ++ +
memGRP78-FaDuf ++++ ++ +++
GRP78 proteinW +++ ± ±
Glut3 proteinW +++ + + +
Mice tumor volume +++ + ++
CK18 (undifferentiation)IHC +++ + ++
NanogIHC ++++ ++ +++ +
p-p53 ser15 (anti-apoptosis)W +++ +++
NanogW ++ ±
Nanog reporter +++ + ++ +
Total 38 18 4 9

Positive and negative determine as high and low expression levels in comparison with the GFP, respectively.

f

flow cytometry

W

immunoblotting assay

IHC

immunochemistry